Dikopoulos, Nektarios

Publishing since 1999 (Senior)

Has published 17 publications in 12 years

Number of publications published per year by Dikopoulos, Nektarios. (Source : PubMed)

Distribution of publications types for Dikopoulos, Nektarios. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Witthoeft T, Hueppe D, John C, Goelz J, Heyne R, Moeller B, Teuber G, Wollschlaeger S, Baumgarten A, Simon KG, Moog G, Dikopoulos N, Mauss S. Efficacy and tolerability of peginterferon alfa-2a or alfa-2b plus ribavirin in the daily routine treatment of patients with chronic hepatitis C in Germany: The PRACTICE Study.  J. Viral Hepat.  2010  
•  Kleger A, Bommer M, Kunze M, Klaus J, Leithaeuser F, Wegener M, Adler G, Dikopoulos N. First reported case of disease: peliosis hepatis as cardinal symptom of Hodgkin's lymphoma.  Oncologist  2009;14;11  
•  Wegert M, La Monica N, Tripodi M, Adler G, Dikopoulos N. Impaired interferon type I signalling in the liver modulates the hepatic acute phase response in hepatitis C virus transgenic mice.  J. Hepatol.  2009;51;2  
•  Zizer E, Hasel C, Seufferlein T, Adler G, Dikopoulos N. [A 40-year-old female patient with seronegative autoimmune hepatitis following a newly acquired hepatitis B infection]  Z Gastroenterol  2008;46;2  
•  Zimmermann M, Flechsig C, La Monica N, Tripodi M, Adler G, Dikopoulos N. Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes.  J. Hepatol.  2008;48;1  
•  Dikopoulos N, Schmid RM, Bachem M, Buttenschoen K, Adler G, Chiang JY, Weidenbach H. Bile synthesis in rat models of inflammatory bowel diseases.  Eur. J. Clin. Invest.  2007;37;3  
•  Wegenka UM, Dikopoulos N, Reimann J, Adler G, Wahl C. The murine liver is a potential target organ for IL-19, IL-20 and IL-24: Type I Interferons and LPS regulate the expression of IL-20R2.  J. Hepatol.  2007;46;2  
•  Dikopoulos N, Bertoletti A, Kröger A, Hauser H, Schirmbeck R, Reimann J. Type I IFN negatively regulates CD8+ T cell responses through IL-10-producing CD4+ T regulatory 1 cells.  J. Immunol.  2005;174;1  
•  Dikopoulos N, Riedl P, Schirmbeck R, Reimann J. Novel peptide-based vaccines efficiently prime murine "help"-independent CD8+ T cell responses in the liver.  Hepatology  2004;40;2  
•  Dikopoulos N, Wegenka U, Kröger A, Hauser H, Schirmbeck R, Reimann J. Recently primed CD8+ T cells entering the liver induce hepatocytes to interact with naïve CD8+ T cells in the mouse.  Hepatology  2004;39;5  

[ See timeline ] [ See all publications ]